Company intelligence / Profile preview
Betta Pharmaceuticals
Hangzhou, Zhejiang, Chinabettapharma.com ↗
- Ownership
- Public · 300558
- Development stage
- Commercial
01
Overview
Betta Pharmaceuticals has successfully developed and commercialized several innovative oncology drugs including Icotinib hydrochloride for NSCLC and Ensartinib hydrochloride for ALK-positive NSCLC. The company also markets a bevacizumab biosimilar. Its pipeline features small molecules and biologics targeting key oncogenic pathways such as EGFR/ALK/c-Met/PD-L1/HIF/TEAD. Several programs are in clinical development for various solid tumors and hematological malignancies
- Therapeutic areas
- OphthalmologyOncology
- Modalities
- Small moleculesmonoclonal antibodies (mAbs)bispecific antibodiesbiosimilars
- Industry
- Biotech
02
Drug pipeline
26 assets25 more assets in the full pipeline.
Request access →03
Partnerships
Sinopharm Group Co., Ltd.Heyuan BiopharmaHangzhou Ruipu ChenchuangEyePoint Pharmaceuticals for EYP‑1901 program
Beyond the preview
Go deeper on Betta Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Betta Pharmaceuticals.